Artwork

Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

HER2-Low Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Identification of HER2-Low Breast Cancer (Companion Faculty Lecture)

39:40
 
Share
 

Manage episode 431713162 series 1464352
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Featuring a slide presentation and related discussion from Dr Kimberly H Allison, including the following topics:

  • Pathological assessment of HER2 and appropriate testing methodologies (0:00)
  • Effect of the DESTINY-Breast04 study on clinical practice (12:32)
  • Relevancy of HER2-ultralow expression and implications of the DESTINY-Breast06 study (22:53)
  • Future directions in the pathological and clinical assessment of HER2-positive breast cancer (31:06)

CME information and select publications

  continue reading

1413 episodes

Artwork
iconShare
 
Manage episode 431713162 series 1464352
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Featuring a slide presentation and related discussion from Dr Kimberly H Allison, including the following topics:

  • Pathological assessment of HER2 and appropriate testing methodologies (0:00)
  • Effect of the DESTINY-Breast04 study on clinical practice (12:32)
  • Relevancy of HER2-ultralow expression and implications of the DESTINY-Breast06 study (22:53)
  • Future directions in the pathological and clinical assessment of HER2-positive breast cancer (31:06)

CME information and select publications

  continue reading

1413 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide